Branden Baptiste, 20, becomes the world's first patient to receive base editing gene therapy for sickle cell disease. The treatment has left him feeling 'more than fine' with no symptoms of the disease. After undergoing chemotherapy and a series of tests, Branden was infused with genetically treated cells in December 2023, allowing his...
Researchers at Memorial Sloan Kettering Cancer Center found that a high fiber plant-based dietary intervention can significantly improve disease progression trajectory in participants with precancerous blood disorder. After 12 weeks, two participants showed a significant improvement and none progressed to multiple myeloma within one year.
Researchers from Tokyo Metropolitan University found that agricultural land preserved around river confluences can reduce flood risks, with stronger correlation near confluence points. This Eco-DRR approach uses existing environmental resources to improve resilience against flooding.
A global clinical trial has shown a significant improvement in disease-free survival rates for children with B-cell acute lymphoblastic leukemia (B-ALL) by combining standard chemotherapy with blinatumomab, an immunotherapy. The study found improved survival rates of up to 97.5% after three years, compared to 90% with chemotherapy alone.
Researchers found that a ketogenic diet's beta-hydroxybutyrate (BHB) improves tumor control and survival in mice with diffuse-large B-cell lymphoma. A BHB supplement also boosts CAR T cell expansion and activation in laboratory models of human cancer.